Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
Press Releases
Benchmark Journal Reviews Key Sector Players
StockPreacher.Com Issues Cautious Trading Outlook for International Coal Group
CNSV Receives Initial Royalty Revenues From Coal Being Mined on a Portion of Its Buckhorn Property.
iCo Therapeutics Q2 2009 Financial Results
International Coal Group Reports Second Quarter 2009 Results
StreetInvesting.Com Free Research on WNR, BLL, CRA, AAV, ICO and NOV
iCo Therapeutics Appoints Infectious Disease MD to Scientific Advisory Board
iCo Therapeutics Closes Non-Brokered Private Placement
International Coal Group Announces Second Quarter 2009 Earnings Release and Conference Call
iCo Therapeutics Diabetic Macular Edema Clinical Trial Update
iCo Therapeutics Publishes Review of Diabetic Retinopathy Treatment
iCo Therapeutics Positive Oral Amphotericin B Data Published in the Journal of Infectious Diseases
Class Action Lawsuit Alleges International Coal Group Shareholders Mislead By Inflated Coal Production Figures: Finkelstein & Krinsk Appointed Lead Counsel
International Coal Group Stockholders Reelect Three Directors at Annual Meeting
Five International Coal Group Mining Operations Receive Safety Awards
International Coal Group Is Lead Sponsor for West Virginia Susan G. Komen Race For The Cure
International Coal Group Reports First Quarter 2009 Results
International Coal Group Announces First Quarter 2009 Earnings Release and Conference Call
iCo Therapeutics Oral Anti-Parasitic Drug to be Presented at Global Health Symposia
iCo Therapeutics iCo-007 Second Cohort Results to be Presented at Cleveland Clinic Ocular Conference
International Coal Group Operations Receive Six Safety and Reclamation Awards
ICG Announces Credit Facility Amendment
iCo Therapeutics Grants Options to New Directors
iCo Therapeutics iCo-007 Results to be Presented at Prestigious Ocular Conference
iCo Therapeutics Oral Amphotericin B Published in Leading Journal
International Coal Group Reports Fourth Quarter and Full Year 2008 Results
iCo Therapeutics Closes $1.3 Million Private Placement
iCo Therapeutics Closes $1.3 Million Private Placement
iCo Therapeutics Closes First Tranche of Non-Brokered Private Placement
International Coal Group Announces Fourth Quarter 2008 Earnings Release and Conference Call
Museum of American Finance Hosts Talk With Wilbur Ross on Obama's Economic Programs
Wolf Run Mining Company To Permanently Close Sago Mine
International Coal Group to Present at Raymond James Coal Investors Conference
iCo Therapeutics Oral Amphotericin B Poster at AAPS
iCo Therapeutics Third Quarter Financial Results
iCo Therapeutics Oral Amphotericin B Effective Against Visceral Leishmaniasis
International Coal Group Reports Third Quarter 2008 Results
International Coal Group Announces Third Quarter 2008 Earnings Release and Conference Call
iCo Therapeutics Provides iCo-009 (Oral Amphotericin B) Pharmacokinetic Results
iCo Therapeutics Selected as Canada's Top 10(TM) Competition Winner
iCo Therapeutics to Present at BioContact Quebec
iCo Therapeutics Provides Interim Trial Results (Diffuse Diabetic Macular Edema)
International Coal Group to Present at Davenport Metals & Mining Symposium
iCo Therapeutics Outlines Steps to First iCo-009 Human Clinical Trial
iCo Therapeutics Second Quarter Financial Results
International Coal Group Reports Second Quarter 2008 Results
International Coal Group's ICG Eastern Subsidiary Wins Top Federal Reclamation Award
International Coal Group Announces Second-Quarter 2008 Earnings Release and Conference Call
International Coal Group Announces Triggering Event for Conversion of $225,000,000 9.00% Convertible Senior Notes Due 2012
iCo Therapeutics Reports New iCo-009 (Oral Amphotericin B) Preclinical Results
iCo Therapeutics Closes $1,140,450 Financing
iCo Therapeutics Announces $1,140,450 Financing
iCo Therapeutics First Quarter Financial Results
International Coal Group Acquires Powell Mountain Mining Operations in Kentucky and Virginia
International Coal Group Stockholders Elect Three Directors - Jun 1 2008 10:54PM
International Coal Group Reports First Quarter 2008 Results
BellwetherReport.com Initiates Analyst Coverage on TMA, PFE, ICO and EPIC
International Coal Group Announces First-Quarter 2008 Earnings Release and Conference Call
Samuel A. Mitchell Named to International Coal Group Board of Directors
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia